NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients

Abstract

Our study has provided the significant clinical relevance of NDUFA4L2 in ccRCC and suggested that ccRCC patients with NDUFA4L2 overexpression may be suitable as a potential therapeutic target for ccRCC patients.